Topic
Prior Authorization
Documentation, step edits, renewal cycles, appeals, and how payer criteria shape real-world drug use.
Policy· May 31, 2026 · 13 min read

Pricing & Access· May 31, 2026 · 13 min read
Step therapy exception evidence for specialty drugs

Pipeline· May 31, 2026 · 8 min read
Tebipenem HBr PDUFA preview for oral carbapenem access
By Ran Chen#PDUFA Date#FDA Approval#Infectious Disease

Pipeline· May 31, 2026 · 10 min read
Veligrotug vs Tepezza thyroid eye disease access guide
By Ran Chen#PDUFA Date#FDA Approval#Ophthalmology

Pricing & Access· May 30, 2026 · 11 min read
Datroway TNBC coverage guide: TROP2 ADC access and coding
By Ran Chen#ADC#Breast Cancer#Prior Authorization

Policy· May 30, 2026 · 11 min read
Medicare GLP-1 Bridge program guide for $50 obesity drug access
By Ran Chen#GLP-1#Medicare Part D#Drug Pricing

Pricing & Access· May 29, 2026 · 12 min read
Foundayo coverage guide: orforglipron access, pricing, and PA criteria
By Ran Chen#GLP-1#Obesity#Prior Authorization

Pricing & Access· May 29, 2026 · 10 min read
Idvynso HIV access guide: PA criteria, switching, and affordability
By Ran Chen#HIV#Infectious Disease#Prior Authorization

Pricing & Access· May 29, 2026 · 10 min read
Tecentriq Hybreza bladder cancer MRD access guide
By Ran Chen#Oncology#PD-L1#Companion Diagnostic

Approvals· May 28, 2026 · 7 min read
Baxfendy coverage guide: baxdrostat access for uncontrolled hypertension
By Ran Chen#Hypertension#Cardiovascular#FDA Approval